KF

Khazi Faizan Saqib

Active Director Director DIN 11867419
DIN 11867419 First appointment Aug 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Khazi Faizan Saqib

Khazi Faizan Saqib is a Director at Niramed Pharmaceuticals Private Limited (since 2026).

DIN 11867419
Primary Designation Director
First Appointment 03 Aug 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Aug 20262026Active

Board colleagues of Khazi Faizan Saqib

NameDINCompanyDesignation
Tazyeen SaherNiramed Pharmaceuticals Private LimitedIndividual Subscriber
Arun Sangappa PattedNiramed Pharmaceuticals Private LimitedIndividual Subscriber
Asra Riyaz11867418Niramed Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Niramed Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Khazi Faizan Saqib

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Khazi Faizan Saqib

Khazi Faizan Saqib currently holds 1 directorship: Niramed Pharmaceuticals Private Limited (Director, since 03 Aug 2026).

Khazi Faizan Saqib was first appointed on 03 Aug 2026 as Director at Niramed Pharmaceuticals Private Limited.

The current boards of Khazi Faizan Saqib's companies include Tazyeen Saher (Niramed Pharmaceuticals Private Limited), Arun Sangappa Patted (Niramed Pharmaceuticals Private Limited), Asra Riyaz (Niramed Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available